Citation
Yang, Xiaoman, et al. "Up-regulation of miR-133a-3p Promotes Ovary Insulin Resistance On Granulosa Cells of Obese PCOS Patients Via Inhibiting PI3K/AKT Signaling." BMC Women's Health, vol. 22, no. 1, 2022, p. 412.
Yang X, Wang K, Lang J, et al. Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling. BMC Womens Health. 2022;22(1):412.
Yang, X., Wang, K., Lang, J., Guo, D., Gao, H., Qiu, Y., Jin, X., Zhang, M., Shi, J., Ma, Q., Ma, Q., & Wen, Z. (2022). Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling. BMC Women's Health, 22(1), 412. https://doi.org/10.1186/s12905-022-01994-6
Yang X, et al. Up-regulation of miR-133a-3p Promotes Ovary Insulin Resistance On Granulosa Cells of Obese PCOS Patients Via Inhibiting PI3K/AKT Signaling. BMC Womens Health. 2022 10 8;22(1):412. PubMed PMID: 36209087.
TY - JOUR
T1 - Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling.
AU - Yang,Xiaoman,
AU - Wang,Kehua,
AU - Lang,Jiajia,
AU - Guo,Danyang,
AU - Gao,Haixia,
AU - Qiu,Yue,
AU - Jin,Xiaohan,
AU - Zhang,Mingyue,
AU - Shi,Jiaxiu,
AU - Ma,QianQian,
AU - Ma,Qian,
AU - Wen,Zixi,
Y1 - 2022/10/08/
PY - 2021/10/21/received
PY - 2022/09/26/accepted
PY - 2022/10/8/entrez
PY - 2022/10/9/pubmed
PY - 2022/10/12/medline
KW - Granulosa cells
KW - Insulin resistance
KW - Obesity
KW - PI3K/AKT signaling
KW - Polycystic ovarian syndrome
KW - miR-133a-3p
SP - 412
EP - 412
JF - BMC women's health
JO - BMC Womens Health
VL - 22
IS - 1
N2 - BACKGROUND: MicroRNAs are a type of non-coding single-stranded RNA, which is involved in the regulation of ovary insulin resistance (IR). This study aims to explore the underlying mechanisms of miR-133a-3p regulating ovary IR in obese polycystic ovary syndrome (PCOS). METHODS: Granulosa cells (GCs) were extracted from follicular fluids of PCOS patients (obese PCOS group and non-obese PCOS group) and healthy women (control group). The expression of miR-133a-3p in GCs was detected by qRT-PCR. The targets and pathways of miR-133a-3p were predicted by bioinformatics analyses. The protein levels of PI3K, p-AKT, GLUT4, p-GSK-3β, and p-FOXO1 were measured by Western blotting. RESULTS: MiR-133a-3p was highly expressed in GCs from PCOS patients, especially in obese PCOS patients. The protein levels of PI3K and p-AKT was downregulated in GCs from PCOS patients. There were 11 target genes of miR-133a-3p enriching in PI3K/AKT signaling pathway. miR-133a-3p mimic downregulated the expression of PI3K, p-AKT, and GLUT4, and upregulated the protein levels of p-GSK-3β and p-FOXO1. miR-133a-3p inhibitor presented the opposite effect of miR-133a-3p mimic. CONCLUSION: MiR-133a-3p promotes ovary IR on GCs of obese PCOS patients via inhibiting PI3K/AKT signaling pathway. This study lays a foundation for further research on the mechanism of ovary IR in obese PCOS patients.
SN - 1472-6874
UR - https://www.unboundmedicine.com/medline/citation/36209087/Up_regulation_of_miR_133a_3p_promotes_ovary_insulin_resistance_on_granulosa_cells_of_obese_PCOS_patients_via_inhibiting_PI3K/AKT_signaling_
DB - PRIME
DP - Unbound Medicine
ER -